The Melanoma Care Coalition

Co-Chairs

John M. Kirkwood, MD
Director, Melanoma and Skin Cancer Program
University of Pittsburgh Cancer Institute
Professor and Vice Chairman for Clinical Research
Department of Medicine
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
*Grants/Research Support: Schering-Plough Corporation, Berlex Laboratories, Pfizer Inc; Consultant: Antigenics Inc, Eleos; Intrexon; MedImmune, Inc; Speakers’ Bureau: Schering-Plough Corporation

John M. Kirkwood, MD, is Director of the Melanoma and Skin Cancer Program at the University of Pittsburgh Cancer Institute and Professor and Vice Chairman for Clinical Research at the University of Pittsburgh School of Medicine. Dr Kirkwood has received international acclaim for his research in biologic agents, cancer vaccines, and molecular changes in melanoma.

Merrick I. Ross, MD, FACS
Professor of Surgical Oncology
University of Texas M.D. Anderson Cancer Center
Houston, Texas
*Speakers’ Bureaus: Schering-Plough Corporation, Genentech, Inc

Merrick I. Ross, MD, FACS, is Professor of Surgery and chief of the Melanoma Section at the Department of Surgical Oncology at the University of Texas M.D. Anderson Cancer Center. The author of over 300 publications, Dr Ross is a world-renowned speaker and expert in the surgical management of melanoma and breast cancer. A former research fellow at the Scripps Clinic and Research Institute, Dr Ross also has extensive research experience with tumor vaccines, immunotherapy, and biologic therapies.

Steering Committee

Rosemary Giuliano, ARNP, MSN
Surgical Hospitalist
Morton Plant North Bay Hospital
New Port Richey, Florida
*Speakers’ Bureau: Schering-Plough Corporation; Consultant: Topo Target

Susan M. Swetter, MD
Associate Professor of Dermatology
Director, Pigmented Lesion & Cutaneous Melanoma Clinic
Stanford University Medical Center/VA Palo Alto Health Care System
Co-Director, Stanford Multidisciplinary Melanoma Clinic
Stanford, California
*Speakers’ Bureau: Schering-Plough Corporation

The Melanoma Care Coalition

Bruce J. Averbook, MD
Associate Professor of Surgery
Metro Health Medical Center
Case Western Reserve University
Cleveland, Ohio
*Speakers’ Bureau: Schering Oncology Biotech

Matthew T. Ballo, MD
Associate Professor of Radiation Oncology
University of Texas M.D. Anderson Cancer Center
Houston, Texas
*No financial relationships to disclose

Ernest C. Borden, MD
Director
Center for Cancer Drug Discovery & Development
Cleveland Clinic Cancer Center and Lerner Research Institute
The Cleveland Clinic Foundation
Cleveland, Ohio
*Consultant: Cleveland Biolabs; Speakers’ Bureaus:
Novartis Pharmaceuticals Corporation, Pfizer Inc

Tania Bridgeman, RN, PhD
Director of Clinical Path Development
University of California, Irvine Medical School
Orange, California
*No financial relationships to disclose

Clara Curiel-Lewandrowski, MD
Assistant Professor of Dermatology
University of Arizona
Tucson, Arizona
*No financial relationships to disclose

David E. Elder, MB, ChB, FRCPA
Professor of Pathology & Laboratory Medicine
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
*Grant Research Support: NIH/NCI, EU Framework

Marc S. Ernstoff, MD
Professor of Medicine
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
*Grants/Research Support: National Institutes of Health, Bristol-Myers
Squibb, Berlex Laboratories, Chiron Inc, Schering-Plough Corporation, Pfizer Inc;
Consultant: Chiron Inc; Speakers’ Bureaus: Berlex Laboratories, Chiron Inc, Schering-Plough Corporation, Pfizer Inc

Lawrence E. Flaherty, MD
Professor of Medicine and Oncology
Karmanos Cancer Institute
Wayne State University
Detroit, Michigan
*Grants/Research Support: Schering-Plough Corporation, Chiron Therapeutics, Celgene,Bayer; Consultant: Bayer; Speaker’s Bureau: Schering-Plough Corporation, Glaxo Smith Kline

James S. Goydos, MD, FACS
Associate Professor of Surgical Oncology
Robert Wood Johnson Medical School
Cancer Institute of New Jersey
New Brunswick, New Jersey
*Speaker’s Bureau: Schering-Plough Corporation

James M. Grichnik, MD, PhD
Associate Professor
Duke University Medical Center
Durham, North Carolina
*Founder and Major Shareholder: DigitalDerm, Inc; Consultant/Grants: Electro-Optical Systems Inc.

Caron M. Grin, MD
Clinical Professor of Dermatology
University of Connecticut Health Center
Farmington, Connecticut
*Speaker’s Bureau: Schering-Plough Corporation

James G. Jakowatz, MD
Director
Melanoma Center
Associate Professor of Surgery
University of California, Irvine Medical Center
Orange, California
*No financial relationships to disclose

Mohammed Kashani-Sabet, MD
Associate Professor of Dermatology
Director, Melanoma Center
UCSF Cancer Center
University of California San Francisco School of Medicine
San Francisco, California
*Consultant: Schering-Plough; Speaker’s Bureau: Schering-Plough Corporation

Douglas Kondziolka, MD, MSc, FRCSC, FACS
Vice-Chairman of Neurological Surgery
Professor of Radiation Oncology
University of Pittsburgh
Pittsburgh, Pennsylvania
*Consultant: Elekta Instruments

David H. Lawson, MD
Professor of Hematology/Oncology
Winship Cancer Institute
Atlanta, Georgia
*Grants/Research Support, Consultant, and Speakers’ Bureaus: Chiron Therapeutics, Schering-Plough Corporation, Berlex Laboratories

Sancy Leachman, MD, PhD
Associate Professor
Huntsman Cancer Institute
Department of Dermatology at the University of Utah Health Sciences Center
Salt Lake City, Utah
*Speaker’s Bureau: Myriad Genetic Laboratories

Patricia K. Long, MSN, FNP
Physician Extender/Nurse Practitioner
University of North Carolina
Chapel Hill, North Carolina
*No financial relationships to disclose

Ashfaq A. Marghoob, MD, FAAD
Associate Clinical Member
Clinical Director, Skin Care Center
Memorial Sloan-Kettering Cancer Center
Hauppauge, New York
*No financial relationships to disclose

R. Dirk Noyes, MD, FACS
Co-Director
Surgical Oncology
Multidisciplinary Melanoma Clinic
University of Utah
Huntsman Cancer Institute
Salt Lake City, Utah
*Speaker’s Bureau: Schering-Plough Corporation

Steven J. O'Day, MD
Chief of Research
Director of Melanoma Program
The Angeles Clinic and Research Institute
Los Angeles, California
*Grants/Research Support: Berlex Laboratories, Chiron Therapeutics, Novartis, Schering-Plough Consultant: Synta Pharmaceuticals

Thomas E. Olencki, DO
Clinical Professor
Division of Hematology/Oncology
James Cancer Hospital and Solove Research Institute
Ohio State University
Columbus, Ohio
*Speakers’ Bureaus: Schering-Plough Corporation

David W. Ollila, MD
Associate Professor of Surgery
Director, Multidisciplinary Melanoma Program
University of North Carolina School of Medicine
Chapel Hill, North Carolina
*No financial relationships to disclose

Victor G. Prieto, MD, PhD
Professor of Pathology
University of Texas M.D. Anderson Cancer Center
Houston, Texas
*No financial relationships to disclose

Douglas S. Reintgen, MD
Director
Lakeland Regional Cancer Center
Lakeland, Florida
*Speaker’s Bureau: Schering Oncology

Krista M. Rubin, MS, RN, FNP-C
Nurse Practitioner
Center for Melanoma
Massachusetts General Hospital
Division of Hematology/Oncology
Boston, Massachusetts
*Speaker’s Bureau: Schering-Plough Corporation

Wolfram Samlowski, MD
Head, Section of Melanoma, Renal Cancer and Immunotherapy
Nevada Cancer Institute
Las Vegas, Nevada
*Grants/Research Support: Pfizer Inc; Speakers Bureaus: Pfizer Inc,
Bayer, AOI, Sci Med; Stockholder: Amgen, Pfizer, Chiron, Glaxo Smith Kline


Vernon K. Sondak, MD

Chief
Division of Cutaneous Oncology
H. Lee Moffitt Cancer Center
Professor
Departments of Interdisciplinary Oncology and Surgery
University of South Florida College of Medicine
Tampa, Florida
*Speakers’ Bureaus: Schering Oncology Biotech, Pfizer Inc

Kenneth K. Tanabe, MD
Chief
Division of Surgical Oncology
Massachusetts General Hospital
Associate Professor of Surgery
Harvard Medical School
Boston, Massachusetts
*Speaker’s Bureau: Schering-Plough Corporation

Alan Valentine, MD
Associate Professor of Medicine
University of Texas M.D. Anderson Cancer Center
Houston, Texas
*No financial relationships to disclose

Robert W. Weber, MD
Associate Director
Northern California Melanoma Center
St Francis Memorial Hospital
San Francisco, California
*No financial relationships to disclose

Richard L. White, Jr, MD, FACS
Clinical Associate Professor
Department of Surgery
Carolinas Medical Center
Blumenthal Cancer Center
Charlotte, North Carolina
*Speakers’ Bureaus: Schering Oncology, Chiron Therapeutics

*Denotes financial disclosure information